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Gestational hypercalciuria causes pathological urine calcium
oxalate supersaturations
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Gestational hypercalciuria causes pathological urine calcium oxalate
supersaturations. Although normal pregnant women are more hypercal-
ciuric than women with calcium oxalate nephrolithiasis (243 23 mg/
day vs. 194 5 mg/day), pregnancy is not an established stone-forming
state and pregnant women do not exhibit pathological crystalluria. One
hypothesis to explain their lack of overt stone formation and patholog-
ical crystalluria is that pregnancy does not raise urine supersaturation
with respect to stone forming salts such as calcium oxalate or calcium
monohydrogen phosphate (brushite) to levels as high as in stone
forming women. To test this hypothesis, we studied eleven normal
women during each trimester of pregnancy, and between six and eight
weeks post-partum. During pregnancy, hypercalciuria occurs with
unchanged urine volume, citrate and magnesium excretions do not
increase proportionally with calcium excretion, and urine pH increases.
Supersaturations with respect to calcium oxalate (CaOx) and brushite
(Br) are as high as those of women with calcium nephrolithiasis. The
lack of pathological crystalluria and stones during pregnancy is not due
to a failure of supersaturations to increase: urinary potential for
crystallization is as high as in patients with established stone disease.
Normal pregnancy causes hypercalciuria. For example, one
study [1] reports the mean calcium excretion of 12 women as
430 15 mg!24 hr, a second [21 reports median values during
the first, second, and third trimesters, respectively of 233, 329
and 305 mg/24 hours, and in a third study [3], mean calcium
excretion was 313 44 mg/24 hr. By comparison, normal
women who are not pregnant excrete 112 7 (sEM) mg/day [4]
when eating uncontrolled diets, and few normal women excrete
more than 250 mg/24 hours [5, 6]. Gestational hypercalciuria
may arise from increased serum levels of 1,25 dihydroxyvitamin
D (calcitriol) [7, 8], a hormone that stimulates intestinal calcium
absorption [9], and can cause normocalcemic hypercalciuria
when given to normal men [101. In one study [71, serum
calcitriol levels (pg/mi) were high during all three trimesters [7]
(94 11, 118 9 and 117 11 vs. 51 5 post-partum; all
pregnancy values P < 0.05 vs. post-partum), and urine calcium
levels also were high: 247 54, 316 42, 300 61 mg/24 hour
vs. 91 18, for the three trimesters versus post-partum.
As a rule, hypercalciuria causes crystalluria and kidney
stones [11—131. Idiopathic hypercalciuria, a familial and proba-
bly hereditary trait [13] that can arise from excessive intestinal
calcium absorption, impaired renal tubule calcium reabsorption
[5], and calcitriol excess [14, 15] is a common putative cause of
calcium oxalate nephrolithiasis. Primary hyperparathyroidism,
sarcoidosis, immobilization, glucocorticoid excess, and vitamin
D intoxication all cause hypercalciuria and calcium oxalate
stones [15—18]. Sarcoidosis is of particular interest here, as
calcitriol excess causes hypercalciuria [19, 20]. Hypercalciuria
with alkaline urine pH causes calcium phosphate stones, as
found in Type I renal tubular acidosis [17, 21—23]. The final
common pathway for stone formation in hypercalciuric states is
excessive urinary supersaturation with respect to calcium salts
[24—26]. Hypercalciuria alone raises mainly calcium oxalate
supersaturation [25]; elevated urine pH raises calcium phos-
phate supersaturations as well [27].
Gestational hypercalciuria is an exception to the rule; preg-
nancy is not a stone forming condition [28, 29], abnormal
crystalluria is not a recognized clinical finding [28, 30], and
stone formers who become pregnant do not increase their stone
production rate [29]. An obvious hypothesis is that gestational
hypercalciuria, unlike other forms of hypercalciuria, is benign
because it does not supersaturate the urine with calcium oxalate
and calcium phosphate salts. We have tested this idea, and
present evidence to the contrary; gestational hypercalciuria
raises urinary calcium oxalate and brushite supersaturations to
levels of women with established recurrent calcium nephrolith-
iasis, so normal pregnant women should be at a high risk for
pathological crystalluria and kidney stone disease. The lack of
stones and overt crystalluria despite high supersaturations
implies that pregnancy induces special and presently undefined
defenses against crystallization, that deserve a proper study.
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Methods
Subjects
We studied 11 women (age 26 to 35 yr, mean 29 3 years)
who had no known diseases and used no medications except
prenatal supplements. Gestation was uncomplicated except for
an intrauterine death from abruptio placentae near term (39 to
40 weeks) in one woman whose fetus had a short, tangled
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Table 1. Values for serum and urine chemistries for normal pregnant women, normal women, and calcium stone-forming women
Normals First Second Third Post-P CaOx CaPhos
Serum
Sodium mEq/iiter 139 0.2 136 Q•3C 137 0.4° 137 0.4° 140 0.5 140 0.2° 140 0.4
Magnesium mg/dl 1.97 0.01 1.93 0.03 1.93 0.03 1.87 0.03° 2.01 0.03 1.97 0.01 1.99 0.02
Uric Acid mg/d!
Phosphorus mg/di
Creatinine mg/dl
3.99 0.12°
3.52 0.06
0.82 0.01°
2.7! 0.16°
3.61 0.09
0.65 0.01°
2.99 027b
3.32 0.08
0.64 0.02°
3.61 0.34
3.30 0.12
0.67 0.03°
4.25 0.36
4.07 0.14"
0.84 0.03
4.24 0.05
3.41 0.02
0.78 001b
3.69 0.14
3.38 0.08
0.78 0.02
Potassium mEqlliter 3.92 0.03 3.98 0.1 3.93 0.04 3.95 0.07 4.23 o.Ila 4.00 0.03 4.08 0.06
Calcium mg/d! 9.40 0.03 9.24 0.10 8.86 0.09' 8.82 0.07° 9.47 0.10 9.45 0.02 9.47 0.04
Urine
Volume mi/day 1215 66 1364 92 1511 130 1504 145 1442 170 1336 35 1752 12°
Sodium mM/day 127 44 146 10 167 17° 125 IS 130 13 128 2 130 7
Calcium mg/day 112 7 238 20° 256 24° 235 25° 75 12° 194 5° 244 4°
Calcium mg/C 0.81 0.05 1.46 015b 1.45 0.14" 1.38 0.16" 0.56 0.08° 1.38 0.03° 1.49 0.10°
Creatinine clearance 153 4 168 8 178 6° 176 10° 133 6° 143 2° 144 4
Potassium mM/day 48 2 55 5 65 5° 66 7° 65 6° 46 1 51 3
Magnesium mEq/day 83 5 109 7b 130 10° 117 7° 84 5 80 2 82 3
Uric Acid mg/day 540 16 524 40 651 44° 687 50° 473 337 509 7 548 25
Phosphorus mg/day 677 20 666 63 665 65 733 54 758 56 713 11 766 33
Oxalate mg/day
Citrate mg/day
26 8
699 42
28 2
731 34
32 3°
933 92°
33 2°
986 87"
26 2
567 58
27 I
505 18'
34 2°
380 59°
Abbreviations are: post-P, post-partum values; CaOx and CaPhos refer to patients who form such stones; Cr creatinine clearance in liters/24
hour; mg/C, mg/liter creatinine clearance.
a Differs from normals, P < 0.05; b p < 0.01; P < 0.001
umbilical cord. One woman developed asthma during mid-
trimester of pregnancy, required oral theophylline, inhaled
sympathomimetic drugs, and oral prednisone, but delivered a
healthy baby at 32 weeks gestation. Although two women were
breast feeding during our post-partum studies, their values did
not differ from the rest of the post-partum group and are merged
in the group means. Two women with abnormal pregnancies,
one with a hydatidiform mole and one with an anephric fetus,
were also studied.
In a separate protocol we determined the relationship be-
tween urine citrate and calcium, and response of urine calcium
and citrate to alkali loading in four normal women age 23 to 29
(mean 26 3 years) eating controlled diets [31, 32].
Study during pregnancy
Blood and urine were obtained once in each trimester of
pregnancy, and at six to eight weeks post-partum. Urine
studies, only, were done before and after evacuation of a
hydatidiform mole in an 18-year-old patient and at approxi-
mately 24 weeks gestation in a 25-year-old primigravida with an
anephric fetus. All subjects collected 24-hour urine samples
while eating their individual diets as out-patients; blood was
drawn at the end of the collection period between 7:30 and 9:00
a.m. Because of morning sickness, not all subjects were fasting
since the preceding midnight as is our usual practice [16].
Sodium, potassium, uric acid, calcium, phosphorus, magne-
sium, and creatinine were measured in blood and urine, and
oxalate, citrate, sulfate, chloride, and pH, along with volume,
in urine only. Supersaturations were calculated using an itera-
tive computer program [33].
Controlled diet alkali study
Four normal women were studied in the Clinical Research
Center (CRC). The basic diet contained 60 mEq sodium, 60
mEqpotassium, 400to 500 mg calcium, 200 mg magnesium, and
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Fig. 1. Urine calcium excretion during pregnancy exceeded the mean
value from our 77 normal women, and post-partum values for the 11
subjects, P < 0.01 all comparisons, all three trimesters.
700 to 800 mg phosphorus. During control periods, we added
140 mEq NaCI to the diet; for alkali loading, we replaced the
140 mEq of NaCl with sodium bicarbonate. Subjects began each
diet seven days before admission to the CRC. Control or alkali
diet was started first or second, at random. Subjects were
admitted to the CRC on the morning of day 8 of the diet period,
continued on the diet for four additional days during testing,
and were discharged on day 12. Twenty-four hour urine collec-
tions were obtained on days 8 through 11, blood was drawn only
on days 8 and II. Calcium, magnesium, creatinine, sodium,
potassium, and bicarbonate were measured in blood and urine.
Oxalate, citrate, and sulfate were measured in urine only, and
supersaturations were calculated using a computer program
[33]. On day II, arterialized venous blood was drawn for
ionized calcium, venous pH and pCO2. After at least a two
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Fig. 2. Urine citrate and calcium concentrations during pregnancy (A)
and in 4 women eating controlled diets (B). Citrate to calcium ratio was
below the line of identity (Diagonal line, both panels) for all three
trimesters (numbered closed circles, panel A), and rose above I
post-partum (pp, A). Open circle in A shows double mean for our
(4) outpatient normal women. Open and closed diamonds, both panels
show data for female calcium oxalate and calcium phosphate stone
formers, respectively. Open and closed circles in B show values for
alkali supplement and control conditions, respectively, for 4 normal
women eating controlled diets and studied in our clinical research
center.
week interval with no dietary constraints the alternate diet was
started and the 11 day protocol was repeated.
Measurements
Sodium and potassium were measured by flame photometry
(Instrumentation Laboratory, Lexington, Massachusetts, USA),
inorganic phosphorus and creatinine by autoanalyzer (Tech-
nicon Instruments Corp., Tarrytown, New York, USA), cal-
cium and magnesium by atomic absorption spectrophotometry
(Video 22, Instrumentation Laboratory), chloride by electro-
chemical titration (Buchler-Cotlove Chloridometer, Buehler
Instruments, Inc., Fort Lee, New Jersey, USA), uric acid by
the uricase method [34], urinary sulfate by turbidometry [35],
citrate using citrate lyase [36], and oxalate by zinc reduction
[37]. Urine pH was measured by pH meter (Beckman 071,
Beckman Instruments, Inc., Fullerton, California, USA). Blood
gas determinations were done on a Radiometer Blood Micro
System (The London Company, Cleveland, Ohio, USA), and
blood ionized calcium was by calcium electrode (Nova 2, Nova
Biochemical, Newton, Massachusetts, USA).
Calculations and analysis of data
Supersaturations were calculated using an iterative computer
model of the relevant ionic interactions in urine and expressed
as the ratio of the concentration of calcium oxalate or brushite
salt in urine to its own solubility [33]. This ratio is called the
relative supersaturation ratio (RSR). Free calcium ion concen-
tration also was calculated by the program. Comparisons be-
tween groups used t-tests without assumption of equal vail-
ances in the two groups [38]. All data are
Results
Normal pregnancy
Throughout pregnancy, urine calcium excretion (Figure 1,
Table I) exceeded values for normal women, and was greater
than or equal to values of women with recurrent stone disease
(Table 1). Total serum calcium decreased throughout gestation
and increased post-partum reaching levels of normal non-gravid
women within the first six weeks (Table I); creatinine clearance
was above normal throughout pregnancy, as expected, and
calcium excretion was above normal expressed per liter of
creatinine clearance.
Although citrate and calcium excretions both increased dur-
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Fig. 3. Urine pH values during pregnancy were not different from
those ofourfemale calcium phosphate stone-formers (6.29 0.09), and
exceeded the mean from our 67 normal women, from our female
calcium oxalate sione-formers (6.04 0.03) and posi-partum values, P
<0.0!, all comparisons.
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ing pregnancy, urine calcium increased more than urine citrate
(Fig. 2A). In healthy non-pregnant women under outpatient
conditions we [4] have reported that urine citrate and calcium
are equimolar; our mean values are reproduced on Figure 2A as
the open circle, and the equimolar line—of identity—is drawn
as well. During all three trimesters, urine citrate concentrations
were less than calcium concentrations (Fig. 2A), and the
departure of the citrate to calcium ratio from 1.0, which is the
distance of each point from the line of identity, was similar to
what we [4] have observed in women with established calcium
oxalate stone disease (open diamond). During the first trimes-
ter, the departure was as extreme as in 35 patients we have
studied who formed calcium phosphate stones (closed dia-
mond), because citrate excretion hardly increased (Table I)
whereas hypercalciuria was extreme (Fig. I, Table 1). Post-
partum, the citrate to calcium ratio rose above normal.
The low urine citrate to calcium ratio during pregnancy is
particularly abnormal when compared to the responses of the
four normal women we studied eating controlled diets. Without
supplemental alkali, they excreted citrate and calcium in equi-
molar amounts (Fig. 2B, closed circles). Mean urine pH was
6.188 (0.1 sEM). Given alkali, they increased their citrate
excretions, so their citrate to calcium molar ratio was in excess
of 2.0 (Fig. 2B, open circles); as expected urine pH rose, to
7.941 (0.06 sEM). The alkali loading data are relevant because
urine pH increases during pregnancy (Fig. 3) to values as high
as, or above those of women with calcium phosphate stones
(legend to Fig. 3). In other words, citrate failed to increase in
parallel with calcium excretion during pregnancy, even though
urine pH rose, whereas during alkali loading citrate increases
even though calcium excretion does not.
Fig. 4. Calculated urine calcium ion
concentrations during pregnancy exceeded
normal values for the 4 normal women eating
control and alkali supplemented diets, and post-
partum values; P < 0.01, all comparisons.
Labelled crosshatched bands are 2 SEM.
Hypercalciuria in excess of hypercitricuria increased calcu-
lated urinary free calcium ion concentration (Fig. 4) to levels
above those observed post-partum, or in our four normal
women eating the control or alkali supplemented diet. By
contrast, alkali loading actually reduced urine calcium ion
concentration (compare shaded regions on Fig. 4). As a result of
the increased free calcium ion level, calcium oxalate supersa-
turation was above normal (Fig. 5A). Because urine pH and
calcium ion concentration both were elevated, brushite super-
saturation increased (Fig. 5B), whereas brushite supersatura-
tion did not rise (legend to Fig. 5) when women were given
alkali.
Serum sodium and uric acid decreased in first trimester, and
remained low (Table 1). Mean urinary volumes during preg-
nancy and post-partum were similar to those in normal and
stone forming women. Magnesium excretion was increased
throughout gestation. In the four women studied in the CRC,
arterialized venous pH and PCO2 values were 7.403 0.006 and
38 1 before, and 7.4 13 0.01 and 40 1 after alkali loading.
Abnormal pregnancy
The woman with the anephric fetus (not illustrated) was
hypercalciuric (233 mg calcium/day) and her citrate excretion
was 534 mglday, yielding a citrate to calcium molar ratio of
0.47. Her urine supersaturations for calcium oxalate and
brushite were 7.64 and 2.95, respectively (both P < 0.001 vs.
normals). The patient with the hydatidiform mole also had
hypercalciuria, 291 mg calcium/day, that decreased to 178 mg/
day by the fifth day after evacuation of the mole. Her initial
citrate excretion was 527 mg/day with a citrate to calcium molar
ratio of 0.38 and calcium oxalate and brushite supersaturations
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Fig. 5. Relative supersaturation ratios for calcium oxalate (A) , and brushite (B) exceeded our normal mean values, post-partum values, and
corresponding values for the 4 normal women studied with (1.24 0.12, brushite, 2.17 0.39, calcium oxalate) and without (1.19 0,24, brushite,
3.34 0.37, calcium oxalate) alkali loading, respectively; P <0.01, all comparisons.
of 10.8 and 9.35, respectively, both P < 0.001 versus normals.
Five days after removal of the mole, her calcium oxalate and
brushite supersaturations were 6.91 and 6.55,respectively, both
P < 0.001 versus normals, but decreased from levels prior to
evacuation.
Discussion
Our principal new finding is that gestational hypercalciuria
elevates urine supersaturations with respect to calcium oxalate
and brushite, two stone forming salts [39, 401. Supersaturation
is as high as in women with established calcium stone disease
and, if our patients have been well chosen, appears universal.
The only prior evidence for increased supersaturations in
pregnancy is in abstracts [31, 32]. The main factor raising
calcium oxalate and calcium phosphate supersaturation is ges-
tational hypercalciuria itself; also important is a decrease in the
citrate to calcium molar ratio from the normal of one to a ratio
of less than one, because urine citrate excretion rises less than
calcium excretion. Brushite supersaturations are further in-
creased by elevated urine pH that is well known [41, 42] and has
been ascribed [41] to renal compensation for the chronic
respiratory alkalosis of pregnancy.
The hypercalciuria of normal pregnancy has been known
since at least 1943 [43]. Increased glomerular filtration rate and
calcium filtration [1], and excess intestinal calcium absorption
due to high circulating levels of calcitriol [7] both are possible
mechanisms. Our study of the patient with the hydatidiform
mole suggests that the placenta is sufficient to cause hypercal-
ciuria. The decrease in total serum calcium level we observed
has been described by others [44] and seems due to a decrease
in plasma albumin with normal ionized calcium [45—471. Gb-
merular filtration rate increased in the first trimester and re-
mained elevated until delivery, as others describe [48, 49]. The
serum calcium change, and increased GFR do not seem related
to the hypercalciuria.
Given that urine calcium oxalate and brushite supersatura-
tions are as high in pregnancy as in patients with established
calcium nephrolithiasis, why has pathological crystalluria not
been an obvious clinical finding, and why is stone formation not
a commonly recognized complication of pregnancy? One pos-
sible explanation is simply that pregnancy lasts only nine
months; though all of the pregnant women in, for example, any
given year accumulate many years at risk, no one woman is
exposed to increased supersaturations for more than nine
months at a time. Perhaps short duration is also why malig-
nancy usually is not a stone forming state despite severe
hypercalciuria [50]. Even so, many women have multiple preg-
nancies and therefore have cumulative hypercalciuria of several
years duration, yet multigravidas are not recognized as being at
increased risk for calcium stones [28].
Another explanation is an increase of protective mechanisms,
perhaps some "inhibitor" of crystallization. Magnesium is an
inhibitor of calcium oxalate crystal growth [51], and its excre-
tion increases in pregnancy but not as much as calcium excre-
tion. Other inhibitors of stone formation such as acidic glyco-
proteins [52, 53] may increase during pregnancy and play a
protective role, and we have presented preliminary evidence to
support this notion [54]. No detailed study of the matter has
been reported.
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